Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.

[1]  T. Aoyagi,et al.  Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer. , 1976, Archives of biochemistry and biophysics.

[2]  H. Umezawa,et al.  Stimulatory effect of bestatin, a new specific inhibitor of aminopeptidases, on the blastogenesis of guinea pig lymphocytes. , 1978, Cellular immunology.

[3]  G. Mathé,et al.  Restoration of impaired immune functions of aged animals by chronic bestatin treatment. , 1979, Immunology.

[4]  T. Aoyagi,et al.  Effect of bestatin on mouse immune system and experimental murine tumors. , 1980, The Journal of antibiotics.

[5]  H. Majima.  PHASE I AND PRELIMINARY PHASE II CLINICAL TRIALS OF BESTATIN , 1981 .

[6]  Kazuyoshi Saito,et al.  PHASE I STUDY OF BESTATIN: (II) CLINICAL TRIAL OF BESTATIN IN MALIGNANT SKIN TUMORS , 1981 .

[7]  K. Orita,et al.  [Experimental and clinical studies of bestatin as an immunomodulator]. , 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[8]  H. Sedlacek,et al.  Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. , 1983, Cancer research.

[9]  D. Schuster,et al.  Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin. , 1983, Biochemical pharmacology.

[10]  F. Abe,et al.  Effect of bestatin on syngeneic tumors in mice. , 1984, Gan.

[11]  H. Sedlacek,et al.  Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems. , 1984, Behring Institute Mitteilungen.

[12]  D. Rich,et al.  Effect of Bestatin on in Vitro Responses of Murine Lymphocytes to T‐Cell Stimuli , 1984, Scandinavian journal of immunology.

[13]  J. Talmadge,et al.  Immunomodulatory and therapeutic properties of bestatin in mice. , 1986, Cancer research.

[14]  H. Umezawa,et al.  Action of ubenimex on aminopeptidase activities in spleen cells and peritoneal macrophages from mice. , 1987, The Journal of antibiotics.

[15]  W. Ershler,et al.  Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. , 1988, Journal of the National Cancer Institute.

[16]  I. Saiki,et al.  Inhibition of Tumor Cell Invasion by Ubenimex (Bestatin) in vitro , 1989, Japanese journal of cancer research : Gann.

[17]  R. Ashmun,et al.  Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. , 1989, The Journal of clinical investigation.

[18]  I. Saiki,et al.  Inhibition of tumor angiogenesis by a synthetic cell-adhesive polypeptide containing the Arg-Gly-Asp (RGD) sequence of fibronectin, poly(RGD). , 1990, Japanese journal of cancer research : Gann.

[19]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[20]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[21]  T. Tsuruo,et al.  Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation , 1993, International journal of cancer.

[22]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[23]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[24]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[25]  S. Fox,et al.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes , 1997, Cancer research.

[26]  R Pasqualini,et al.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. , 2000, Cancer research.

[27]  K. Wierzba,et al.  A Potential Use of a Synthetic Retinoid TAC‐101 as an Orally Active Agent That Blocks Angiogenesis in Liver Metastases of Human Stomach Cancer Cells , 2001, Japanese journal of cancer research : Gann.

[28]  J. Denekamp.  Vascular attack as a therapeutic strategy for cancer , 1990, Cancer and Metastasis Reviews.

[29]  I. Saiki,et al.  Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin) , 2004, Clinical & Experimental Metastasis.

[30]  T. Tsuruo,et al.  Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13 , 1995, Clinical & Experimental Metastasis.

[31]  I. Saiki,et al.  Inhibition of lymphangiogenesis‐related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270 , 2004, Cancer science.